Michael Rand Medal
At its meeting in December 1992, the Council of ASCEPT agreed to establish an award in the name of Professor Michael Rand, who retired from the Chair of Pharmacology at the University of Melbourne at the end of 1992, in recognition of his enormous contribution to Australian Pharmacology and to ASCEPT. The Rand Medal will be awarded to a member of ASCEPT whose research has made an outstanding contribution nationally and internationally to the disciplines of clinical or experimental pharmacology or toxicology. [eyesonly logged=”in”]The award will be given biennially and will consist of a medal and $1000*, or as determined by Council from time to time. The medal is awarded in each odd year.
Membership in ASCEPT is a prerequisite for nomination as a candidate. There are no restrictions on the institutional affiliation or age of a candidate. Candidates must be nominated and seconded by 2 ASCEPT members. An ASCEPT member may not nominate, or second, more than one candidate in a year.
The award is made on the basis of the quality of the candidate’s published work and a supporting statement from the nominators. These will be judged by a special Award Committee appointed by the Executive of ASCEPT.
1. A two to four page (A4) summary describing the candidate’s major research achievements and its significance.
2. A full curriculum vitae of the candidate.
3. The candidate’s list of refereed publications.
The recipient will be invited by the President of ASCEPT to deliver a special lecture during the Annual Scientific Meeting of ASCEPT in the year of the Award. Formal presentation of the award will be made to the recipient at the conclusion of this lecture.
|1993||Graham Johnston||GABA eceptors – As Complex as ABC?|
|1995||Susan Pond||Illumination of Therapeutics by Toxicology|
|1997||Bevan Jarrott||Design and serendipity in the quest for novel neuroprotective drugs|
|1999||Don Birkett||Peripatetic paths in research: from biochemistry via drug metabolism to drug utilisation|
|2001||John Miners||The evolution of drug metabolism: Hitchhiking on the technology bandwagon|
|2003||Roger Summers||The Janus faces of adrenoceptors|
|2005||Geoffrey Burnstock||Purinergic Signalling’: history and therapeutic potential|
|2007||Michael Roberts||Seeking to Improve Therapeutic Outcomes Through Research|
|2009||Phillip Beart||Design and Serendipity in Pursuit of Neuroprotection|
|2009||Peter MacKenzie||The UDP Glycosyltransferases; a Versatile Defense Against Chemical Insult|
|2011||Greggory Dusting||Adventures in Pharmacology: From prostaglandins to tissue engineering and a bionic eye|
|2013||Arthur Christopoulos||Reciprocal relationships: The role of ‘topography’ in drug discovery|
*Please note: The Australian Tax Office requires us to obtain an ABN from the recipient or 48.5% must be withheld and forwarded to the Tax Office.
[eyesonly logged=”in” hide=”yes”]
Further information about this award is only available to members. Please login to view.